Brown & Black Bio Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-07-2024
- Paid Up Capital ₹ 2.00 M
as on 17-07-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.05 Cr
as on 17-07-2024
- Satisfied Charges ₹ 5.95 Cr
as on 17-07-2024
- Revenue -56.82%
(FY 2022)
- Profit -67.44%
(FY 2022)
- Ebitda 133.65%
(FY 2022)
- Net Worth 3.77%
(FY 2022)
- Total Assets 0.68%
(FY 2022)
About Brown & Black Bio
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.05 Cr. The company has closed loans amounting to ₹5.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sharad Gupta and Bhupendra Shekhawat serve as directors at the Company.
- CIN/LLPIN
U24232RJ2012PTC038029
- Company No.
038029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2012
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Brown & Black Bio Private Limited offer?
Brown & Black Bio Private Limited offers a wide range of products and services, including Antiallergic API, Cyproheptadine HCL API, Herbal Cough Syrup, Ayurvedic Cough Syrup, Protein Powder, Vegetarian Protein, Ayurvedic Digestive Medicine, Digestive Enzyme Syrup, Pharmaceutical Medicine, Lycopene Syrup.
Who are the key members and board of directors at Brown & Black Bio?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Gupta  | Director | 24-Feb-2012 | Current |
| Bhupendra Shekhawat | Director | 02-May-2013 | Current |
Financial Performance of Brown & Black Bio.
Brown & Black Bio Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.82% decrease. The company also saw a substantial fall in profitability, with a 67.44% decrease in profit. The company's net worth moved up by a moderate rise of 3.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brown & Black Bio?
In 2022, Brown & Black Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Feb 2023 | ₹2.90 Cr | Open |
Others Creation Date: 06 Feb 2023 | ₹1.54 M | Open |
Others Creation Date: 04 Jun 2021 | ₹3.24 Cr | Satisfied |
How Many Employees Work at Brown & Black Bio?
Unlock and access historical data on people associated with Brown & Black Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brown & Black Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brown & Black Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
